Literature DB >> 3343591

Antecedents and consequences of cocaine abuse among opioid addicts. A 2.5-year follow-up.

T R Kosten1, B J Rounsaville, H D Kleber.   

Abstract

During a 2.5-year follow-up of opioid addicts, we examined psychosocial antecedents and consequences of the onset and remission of cocaine abuse. Patients who never used cocaine were compared with those whose use increased or decreased along several dimensions of treatment outcome including drug abuse, legal, employment, family, social, psychological, and medical problems. Cocaine abuse had a marked impact on almost every outcome area except medical problems. Patients whose cocaine use increased during follow-up had more severe problems than either those whose use decreased or those who never used cocaine. Furthermore, the attainment of cocaine abstinence among abusers was associated with improved psychosocial functioning, whereas the onset of cocaine abuse was associated with increased problem severity. Compared with drug-free and detoxification alone treatments, methadone maintenance may minimize legal complications of cocaine abuse, but otherwise it did not significantly reduce psychosocial morbidity from increasing cocaine abuse. These findings suggest that treatment-seeking opioid addicts are vulnerable to wide-ranging deterioration when they become increasingly involved with cocaine but that with the attainment of abstinence many problem areas improve.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3343591     DOI: 10.1097/00005053-198803000-00006

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  16 in total

1.  Cost effectiveness of disulfiram: treating cocaine use in methadone-maintained patients.

Authors:  Mireia Jofre-Bonet; Jody L Sindelar; Ismene L Petrakis; Charla Nich; Tami Frankforter; Bruce J Rounsaville; Kathleen M Carroll
Journal:  J Subst Abuse Treat       Date:  2004-04

2.  Self-administration of cocaine and remifentanil by monkeys: choice between single drugs and mixtures.

Authors:  Kevin B Freeman; William L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  2010-12-30       Impact factor: 4.530

3.  Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment.

Authors:  Jonathan D Savant; Declan T Barry; Christopher J Cutter; Michelle T Joy; An Dinh; Richard S Schottenfeld; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2012-07-06       Impact factor: 4.492

4.  Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).

Authors:  Benedikt Fischer; Jürgen Rehm; Suzanne Brissette; Serge Brochu; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Phil Mun; Dolly Baliunas
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

Review 5.  Methadone maintenance in the treatment of opioid dependence. A current perspective.

Authors:  J E Zweben; J T Payte
Journal:  West J Med       Date:  1990-05

6.  What happens in treatment doesn't stay in treatment: cocaine abstinence during treatment is associated with fewer problems at follow-up.

Authors:  Brian D Kiluk; Charla Nich; Katie Witkiewitz; Theresa A Babuscio; Kathleen M Carroll
Journal:  J Consult Clin Psychol       Date:  2014-03-17

7.  Evaluating a longitudinal mediation model of perceived stress, depressive symptoms, and substance use treatment outcomes.

Authors:  Corey R Roos; Brian D Kiluk; R Kathryn McHugh; Kathleen M Carroll
Journal:  Psychol Addict Behav       Date:  2020-04-16

8.  Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase.

Authors:  Thomas R Kosten; Guiying Wu; Wen Huang; Mark J Harding; Sara C Hamon; Jaakko Lappalainen; David A Nielsen
Journal:  Biol Psychiatry       Date:  2012-08-18       Impact factor: 13.382

9.  Buprenorphine medication versus voucher contingencies in promoting abstinence from opioids and cocaine.

Authors:  Mohit P Chopra; Reid D Landes; Kirstin M Gatchalian; Lisa C Jackson; August R Buchhalter; Maxine L Stitzer; Lisa A Marsch; Warren K Bickel
Journal:  Exp Clin Psychopharmacol       Date:  2009-08       Impact factor: 3.157

10.  Heroin and cocaine co-use in a group of injection drug users in Montréal.

Authors:  Francesco Leri; Jane Stewart; Annie Tremblay; Julie Bruneau
Journal:  J Psychiatry Neurosci       Date:  2004-01       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.